Telix Pharmaceuticals (NasdaqGS:TLX) FY Conference September 08, 2025 04:50 PM ET Company ParticipantsChristian Behrenbruch - MD & Group CEOConference Call ParticipantsDavid Bailey - Equity Research AnalystDavid BaileyGood afternoon, everyone. We're here with the second live session of the day. My name is David Baley. I'm part of the Australian Healthcare Team at Morgan Stanley. Before we get going, I just have to read this out quickly. For important disclosures, please see the Morgan Stanley Research Discl ...